Literature DB >> 16344657

Validity of the Clinical Adaptive Test (CAT)/Clinical Linguistic and Auditory Milestone Scale (CLAMS) as a screening instrument for very low birth weight infants in Taiwan.

Lan-Wan Wang1, Shan-Tair Wang, Chao-Ching Huang.   

Abstract

The authors investigated the validity of the Clinical Adaptive Test (CAT)/Clinical Linguistic and Auditory Milestone Scale (CLAMS) for developmental screening and early prediction in very low birth weight (VLBW) infants, using the Bayley Scales of Infant Development II (BSID-II) as a reference standard. A total of 808 VLBW infants discharged from neonatal intensive care units in Taiwan from January 1995 to December 1997 were enrolled and followed up at the corrected ages of 6, 12, 18, and 24 months. The CAT/CLAMS and BSID-II were performed separately during each visit. The CAT/CLAMS showed strong concurrent correlations (r = 0.51-0.86, p < .0001) with BSID-II mental developmental index (MDI), and had high conegativity scores (96.7%-100%) but low copositivity scores (30.0%-45.3%) for detecting developmental delay. At 24 months of age, the CAT/CLAMS had better predictive validity for significant (MDI <70) rather than borderline (MDI = 70-84) developmental delay. The authors conclude that the CAT/CLAMS is not an appropriate developmental instrument for screening and early prediction in VLBW infants in Taiwan.

Entities:  

Mesh:

Year:  2005        PMID: 16344657     DOI: 10.1097/00004703-200512000-00004

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  2 in total

1.  Early clinical indicators of developmental outcome in abusive head trauma.

Authors:  Mary V Greiner; Alice P Lawrence; Paul Horn; Amy J Newmeyer; Kathi L Makoroff
Journal:  Childs Nerv Syst       Date:  2012-02-25       Impact factor: 1.475

2.  Comparing Two Early Child Development Assessment Tools in Rural Limpopo, South Africa.

Authors:  Gwyneth Milbrath; Claire Constance; Audrey Ogendi; James Plews-Ogan
Journal:  BMC Pediatr       Date:  2020-05-07       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.